HomeCompareVPAHF vs PLD

VPAHF vs PLD: Dividend Comparison 2026

VPAHF yields 270.27% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VPAHF wins by $753.52M in total portfolio value
10 years
VPAHF
VPAHF
● Live price
270.27%
Share price
$0.74
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$759.43M
Annual income
$439,524,286.02
Full VPAHF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — VPAHF vs PLD

📍 VPAHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVPAHFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VPAHF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VPAHF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VPAHF
Annual income on $10K today (after 15% tax)
$22,972.97/yr
After 10yr DRIP, annual income (after tax)
$373,595,643.12/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, VPAHF beats the other by $369,557,526.71/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VPAHF + PLD for your $10,000?

VPAHF: 50%PLD: 50%
100% PLD50/50100% VPAHF
Portfolio after 10yr
$382.67M
Annual income
$222,137,505.60/yr
Blended yield
58.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

VPAHF
No analyst data
Altman Z
2.9
Piotroski
3/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VPAHF buys
0
PLD buys
0
No recent congressional trades found for VPAHF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVPAHFPLD
Forward yield270.27%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$759.43M$5.91M
Annual income after 10y$439,524,286.02$4,750,725.19
Total dividends collected$726.21M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: VPAHF vs PLD ($10,000, DRIP)

YearVPAHF PortfolioVPAHF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$37,727$27,027.03$11,241$540.96+$26.5KVPAHF
2$135,662$95,294.33$13,019$991.13+$122.6KVPAHF
3$465,409$320,250.45$15,801$1,870.97+$449.6KVPAHF
4$1,524,778$1,026,790.34$20,609$3,701.21+$1.50MVPAHF
5$4,775,420$3,143,907.74$29,919$7,867.97+$4.75MVPAHF
6$14,311,885$9,202,185.51$50,631$18,617.74+$14.26MVPAHF
7$41,088,348$25,774,630.79$105,528$51,352.20+$40.98MVPAHF
8$113,120,635$69,156,102.86$287,364$174,449.42+$112.83MVPAHF
9$298,977,565$177,938,485.31$1,081,760$774,280.77+$297.90MVPAHF
10$759,430,280$439,524,286.02$5,908,209$4,750,725.19+$753.52MVPAHF

VPAHF vs PLD: Complete Analysis 2026

VPAHFStock

Volpara Health Technologies Limited provides breast imaging analytics software products in New Zealand. The company offers Volpara Analytics, a software that optimize breast cancer screening operations; Volpara Live, which provides instant patient-based image quality feedback; Volpara Lung, a patient management software that streamlines lung screening workflow; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses TC8 to calculate patients' risk of developing breast cancer; Volpara Risk Pathways, a program for identifying and managing high-risk breast cancer screening patients; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products. In addition, the company provides TruDensity, a Volpara clinical function; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. It operates in North America, the Asia Pacific, Europe, the Middle East, and Africa. Volpara Health Technologies Limited has a strategic relationship with RevealDx. The company was incorporated in 2009 and is headquartered in Wellington, New Zealand.

Full VPAHF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this VPAHF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VPAHF vs SCHDVPAHF vs JEPIVPAHF vs OVPAHF vs KOVPAHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.